Get the content you want anytime you want.
REGISTER NOW | SIGN IN

Latest News From Contagion® Live

Latest News

The ID Pipeline: FDA Activity From the Week of February 9, 2020
Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of February 9, 2020.
Recalls That Should Be on Your Radar—Week of February 9, 2020
We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.
Top Infectious Disease News of the Week—February 9, 2020
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Experts Call For New Pneumococcal Vaccine Strategies
Pneumococcal conjugate vaccines have been effective at reducing pneumonia, sepsis, and bacteremia in immunized populations. Pneumococcal meningitis, however, remains a significant challenge.
 
Missing Early Intervention Leads to Costly Hospital Stays for Patients With HIV
People living with HIV who don’t receive early intervention and primary care end up with a disproportionate share of health care costs, according to a new study that examined barriers to care and costs at a Dublin hospital.
Transitioning From Adequate to Optimal Therapy in <i>Staphylococcus aureus</i> Bacteremia
Therapy options have increased in recent decades, yet there is a lack of guidance. 
Prematurity Plus Lower Respiratory Tract Illness Carries Real Risks
Social and biological factors increase the risk of respiratory failure and death in vulnerable pre-term infants, a new study shows.
Most People Who Inject Drugs Miss Opportunities for HIV, HCV Testing
PWID are unlikely to receive testing for HIV and hepatitis C, according to a new study that found that 8.5% were tested for HIV and 7.7% were tested for HCV within 1 year of a clinical encounter consistent with injection drug use.
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?